Results 171 to 180 of about 574,463 (401)

Preeclampsia and risk of breast cancer: A longitudinal cohort study of tumor histology

International Journal of Cancer, EarlyView.
What's New? Preeclampsia is protective against breast cancer, but it is not clear if the effect extends to all breast tumors. This study examined the association between preeclampsia and breast tumor histology. The findings suggest that the protective effect of preeclampsia is concentrated among ductal and lobular tumors, but not other tumors. Patients
Shu Qin Wei, Valérie Leduc, Brian Potter, Gilles Paradis, Aimina Ayoub, Jessica Healy‐Profitós, Amanda Maniraho, Antoine Lewin, Nathalie Auger   +8 more
wiley   +1 more source

The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: A pragmatic guide for diagnosis, management, and care #

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2015
M. Hod, A. Kapur, D. Sacks, E. Hadar, M. Agarwal, G. D. Di Renzo, L. C. Roura, H. Mcintyre, Jessica L. Morris, H. Divakar   +9 more
semanticscholar   +2 more sources

Assessment of patient safety culture among the staff of the University Hospital for Gynecology and Obstetrics in Alexandria, Egypt. [PDF]

J Egypt Public Health Assoc, 2022
Ali Ali HM, Abdul-Aziz AM, Darwish EAF, Swelem MS, Sultan EA.   +4 more
europepmc   +1 more source

Obstetrics and Gynecology [PDF]

, 2008
中島 彰俊, 中村 隆文, 日高 隆雄, 柳楽 清文, 若杉 聡美, 齋藤 滋   +5 more
core   +2 more sources

Invasive disease‐free and overall survival after (neo)adjuvant chemotherapy in postmenopausal patients with hormone receptor‐positive, HER2‐negative early breast cancer treated with upfront letrozole: Experiences from the phase IV PreFace trial

International Journal of Cancer, EarlyView.
What's New? Neoadjuvant chemotherapy (NACT) can be highly effective for patients with early‐stage breast cancer. Patients with hormone receptor‐positive (HRpos), HER2‐negative (HER2neg) breast cancer, however, may benefit less from NACT. Here, the authors investigated survival outcomes with adjuvant chemotherapy or NACT in a population of ...
Milena Beierlein, Lothar Häberle, Naiba Nabieva, Nicolai Maass, Bahriye Aktas, Sherko Kümmel, Christoph Thomssen, Christopher Wolf, Hans‐Christian Kolberg, Cosima Brucker, Wolfgang Janni, Peter Dall, Andreas Schneeweiss, Frederik Marme, Marc W. Sütterlin, Matthias Ruebner, Anna‐Katharin Theuser, Nadine M. Hofmann, Sybille Böhm, Katrin Almstedt, Sara Kellner, Paul Gass, Hans‐Joachim Lück, Alexander Hein, Sabine Schmatloch, Matthias Kalder, Christoph Uleer, Ingolf Juhasz‐Böss, Volker Hanf, Christian Jackisch, Volkmar Müller, Brigitte Rack, Erik Belleville, Diethelm Wallwiener, Achim Rody, Claudia Rauh, Chistian M. Bayer, Sabrina Uhrig, Hanna Huebner, Chloë Goossens, Sara Y. Brucker, Carolin C. Hack, Tanja N. Fehm, Peter A. Fasching   +43 more
wiley   +1 more source

SARS-CoV-2 Vaccines and Adverse Effects in Gynecology and Obstetrics: The First Italian Retrospective Study. [PDF]

Int J Environ Res Public Health, 2022
Dellino M, Lamanna B, Vinciguerra M, Tafuri S, Stefanizzi P, Malvasi A, Di Vagno G, Cormio G, Loizzi V, Cazzato G, Tinelli R, Cicinelli E, Pinto V, Daniele A, Maiorano E, Resta L, De Vito D, Scacco S, Cascardi E.   +18 more
europepmc   +1 more source

The 1950 Year Book of Obstetrics and Gynecology (August, 1949-July, 1950) [PDF]

, 1951

openalex   +1 more source

Genetically determined body mass index is associated with diffuse large B‐cell lymphoma in polygenic and Mendelian randomization analyses

International Journal of Cancer, EarlyView.
What's New? Obesity has been linked to the risk of non‐Hodgkin lymphoma (NHL), but the evidence remains inconclusive. Here, the authors investigate the possibility of shared genetic risk factors between obesity and four common NHL types. Drawing on data from 8 genome‐wide association studies, they found that a higher genetically determined BMI was ...
Amy Moore, Eleanor Kane, Lauren R. Teras, Mitchell J. Machiela, Joshua Arias, Orestis A. Panagiotou, Alain Monnereau, Nicole Wong Doo, Zhaoming Wang, Susan L. Slager, Roel C. H. Vermeulen, Claire M. Vajdic, Karin E. Smedby, John J. Spinelli, Joseph Vijai, Graham G. Giles, Brian K. Link, Alan A. Arslan, Alexandra Nieters, Paige M. Bracci, Nicola J. Camp, Gilles Salles, Wendy Cozen, Henrik Hjalgrim, Immaculata De Vivo, Hans‐Olov Adami, Demetrius Albanes, Nikolaus Becker, Yolanda Benavente, Simonetta Bisanzi, Paolo Boffetta, Paul Brennan, Angela R. Brooks‐Wilson, Federico Canzian, Jacqueline Clavel, Lucia Conde, David G. Cox, Karen Curtin, Lenka Foretova, Hervé Ghesquières, Bengt Glimelius, Thomas M. Habermann, Jonathan N. Hofmann, Qing Lan, Mark Liebow, Anne Lincoln, Marc Maynadie, James McKay, Mads Melbye, Lucia Miligi, Roger L. Milne, Thierry J. Molina, Lindsay M. Morton, Kari E. North, Kenneth Offit, Marina Padoan, Sara Piro, Alpa V. Patel, Mark P. Purdue, Vignesh Ravichandran, Elio Riboli, Richard K. Severson, Melissa C. Southey, Anthony Staines, Lesley F. Tinker, Ruth C. Travis, Sophia S. Wang, Elisabete Weiderpass, Stephanie Weinstein, Tongzhang Zheng, Stephen J. Chanock, Nathaniel Rothman, Brenda M. Birmann, James R. Cerhan, Sonja I. Berndt   +74 more
wiley   +1 more source

Obstetrics and Gynecology [PDF]

, 2017
中島 彰俊, 吉野 修, 塩﨑 有宏, 島 友子, 米田 哲, 米田 徳子, 鮫島 梓, 齋藤 滋   +7 more
core   +5 more sources

Molecular analysis of the evolutionary history of endometrial and ovarian carcinoma in Lynch syndrome

International Journal of Cancer, EarlyView.
What's New? Lynch syndrome is a prevalent cause of hereditary gynecological cancers, but the timeline of molecular alterations preceding malignancy remains unclear. By studying consecutive surveillance specimens for up to 15 years before cancer diagnosis, the authors found that atypical endometrial hyperplasia was indistinguishable from endometrial and
Anni K. Kauppinen, Alisa P. Olkinuora, Jukka‐Pekka Mecklin, Päivi T. Peltomäki   +3 more
wiley   +1 more source